BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 16, 2010
View Archived Issues
Primate Spinal Cord Recovery Greater than Rat Studies Show
Read More
'Stratified Medicine' Shatters Bio-Pharma Partnering Model
Read More
Stock Movers
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Specialty Pharma Firm AcelRx Joins IPO Queue: $86M Filing
AcelRx Pharmaceuticals Inc. joined the initial public offering (IPO) queue, filing to raise up to $86.25 million in its debut. (BioWorld Today)
Read More
Cerulean Pushing Nano-based Pipeline via $24M Series C
Read More
AHA Roundup
Read More